Table 2.
Qualitative demographic information of parallel RCT of MGOS vs metronidazole vs placebo on vaginitis patients
| Variables | Metronidazole number (%) | Placebo number (%) | MOGS number (%) | p value |
|---|---|---|---|---|
| Job | 0.834 | |||
|
-Self-employment -Employee -University student / Housekeeper |
1 (2.5%) 5 (12.5%) 34 (85.0%) |
3 (7.5%) 6 (15.0%) 31 (77.5%) |
3 (7.5%) 5 (12.5%) 32 (80.0%) |
|
| Education | 0.904 | |||
|
-Illiterate -Literacy -Third grade of middle school -High school diploma -College education |
1 (2.5%) 11 (27.5%) 9 (22.5%) 11 (27.5%) 8 (20.0%) |
2 (5.0%) 9 (22.5%) 8 (20.0%) 11 (27.5%) 10 (25.0%) |
1 (2.5%) 7 (17.5%) 6 (15.0%) 16 (40.0%) 10 (25.0%) |
|
| Husband job | 0.554 | |||
|
-Self-employment -Employee -University student / Housekeeper -No husband: died or divorced |
27 (67.5%) 11 (27.5%) 1 (2.5%) 1 (2.5%) |
24 (60.0%) 11 (27.5%) 0 (0.0%) 5 (12.5%) |
26 (65%) 12 (30.0%) 0 (0.0%) 2 (5.0%) |
|
| Husband education | 0.257 | |||
|
-Illiterate -Literacy -Third grade of middle school -High school diploma -College education -No husband: died or divorced |
0 (0.0%) 6 (15.0%) 8 (20.0%) 16 (40.0%) 9 (22.5%) 1 (2.5%) |
1 (2.5%) 6 (15.0%) 7 (17.5%) 6 (15.0%) 15 (37.5%) 5 (12.5%) |
1 (2.5%) 5 (12.5%) 5 (12.5%) 15 (37.5%) 12 (30.0%) 2 (5.0%) |
|
| Menstrual interval | 0.579 | |||
|
-Regular -Irregular interval, spotting -No, postmenopausal or hysterectomy |
18 (45.0%) 14 (35.0%) 8 (20.0%) |
19 (47.5%) 15 (37.5%) 6 (15.0%) |
21 (52.5%) 9 (22.5%) 10 (25.0%) |
|
| Menstrual during study | 0.231 | |||
|
-Yes -No |
4 (10.0%) 36 (90.0%) |
7 (17.5%) 33 (82.5%) |
2 (5.0%) 38 (95.0%) |
|
| Bleeding after intercourse | 0.289 | |||
|
-No -Yes -No intercourse |
38 (95.0%) 1 (2.5%) 1 (2.5%) |
32 (80.0%) 3 (7.5%) 5 (12.5%) |
34 (85.0%) 4 (10.0%) 2 (5.0%) |
|
| Consumption of probiotic products* | 1.000 | |||
|
-No -Yes |
6 (15.0%) 34 (85.0%) |
6 (15.0%) 34 (85.0%) |
7 (17.5%) 33 (82.5%) |
|
| Pap smear | 0.508 | |||
|
-Normal -Abnormal |
30 (93.8%) 2 (6.3%) |
28 (84.8%) 5 (15.2%) |
28 (84.8%) 5 (15.2%) |
|
| OCP consumption | 0.068 | |||
|
-use -not use |
0 (0.0%) 40 (100.0%) |
2 (5.0%) 38 (95.0%) |
5 (12.5%) 35 (87.5%) |
Data are presented as number (%); * Oral consumption has been considered; MOGS: Myrtle and oak gall suppository